Mohd Talha Noor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohd Talha Noor has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Bhagwan Singh Thakur
Department of Gastroenterology, Sri Aurobindo Medical College and Postgraduate Institute, Indore-Ujjain State Highway, Indore, Madhya Pradesh 453555, India
4 shared publications- Ravindra Kumar
ICMR-National Institute of Research in Tribal Health, Jabalpur, India
3 shared publications Bhagwan S. Thakur
Department of Gastroenterology, Sri Aurobindo Institute of Medical Sciences, Indore, M.P., 453555, India
2 shared publicationsManish Tiwari
2 shared publicationsNivesh Seehra
Department of Gastroenterology, Sri Aurobindo Medical College and Postgraduate Institute, Indore-Ujjain State Highway, Indore, Madhya Pradesh 453555, India
2 shared publications- Piyush Manoria
Department of Gastroenterology, Bhopal Memorial Hospital and Research Centre, Bhopal, Madhya Pradesh, India
2 shared publications
Latest Publications
- 8 April 2025
- Published by Elsevier in Human Immunology
- Vol. 86 (3) , 111305
Correlation of serum vitamin D levels with serum interleukin-23 levels in patients of ulcerative colitis
- 8 April 2025
- Published by Elsevier in Human Immunology
- Vol. 86 (3) , 111305
Correlation of serum vitamin D levels with serum interleukin-23 levels in patients of ulcerative colitis
- Open Access
- 28 December 2024
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e76545
Experience of Endoscopic Dilatation of Esophageal Strictures in a Tertiary Care Hospital: A Study From Central India
Background Endoscopic dilatation is the cornerstone therapy for esophageal strictures. The primary indication for dilatation is to provide immediate and durable symptomatic relief from dysphagia. Following esophageal dilatation, the two most common major consequences are bleeding and perforation, both of which are quite rare. Post-radiation and caustic strictures continue to be a common source of recurrent and refractory strictures that require multiple dilatations, despite a variety of therapeutic techniques. There is a lack of studies dealing with the efficacy and safety of the procedure. Therefore, this study was conducted to explore the effectiveness and application of the Savary-Gilliard dilatation of strictures, as well as the factors influencing the outcome. Methods We recruited patients of dysphagia of various grades having esophageal strictures of various etiologies. The dilatation sessions were done as an outpatient procedure in the majority of patients. In all patients, preprocedural workups, such as routine investigations and esophagogastroduodenoscopy, were done. Contrast-enhanced computed tomography scans of the abdomen and barium swallow examination were done in selected patients. Results of dilatation using wire-guided dilators were reported as the number of dilatations per stricture according to their location and the mean number of sessions required to achieve the target diameter (15 mm). Evaluating clinical efficacy and adverse events were the main goals. Results A total of 250 dilatations were carried out in 112 patients, of whom 67 were females and 45 were males. The mean age of the study population was 50.38 ± 15.4 years. Post-radiation stricture was the commonest. Strictures of upper esophageal origin required the highest number of sessions (2.21 ± 0.78) for adequate dilatation compared to the middle (2.14 ± 0.83) and lower locations (1.7 ± 0.78) with a p-value of 0.004. Post-corrosive upper esophageal stricture required a greater number of sessions for adequate dilatation as compared to post-radiation strictures (3.0 ± 0 vs. 2.6 ± 0.63) with a p-value of 0.005. Conclusion Esophageal dilation for strictures produces a good outcome with minimal adverse effects or major complications. Post-radiation, post-surgical, and post-corrosive strictures are more likely to require repeated sessions for symptomatic relief.
- 28 December 2024
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e76545
Open AccessExperience of Endoscopic Dilatation of Esophageal Strictures in a Tertiary Care Hospital: A Study From Central India
Background Endoscopic dilatation is the cornerstone therapy for esophageal strictures. The primary indication for dilatation is to provide immediate and durable symptomatic relief from dysphagia. Following esophageal dilatation, the two most common major consequences are bleeding and perforation, both of which are quite rare. Post-radiation and caustic strictures continue to be a common source of recurrent and refractory strictures that require multiple dilatations, despite a variety of therapeutic techniques. There is a lack of studies dealing with the efficacy and safety of the procedure. Therefore, this study was conducted to explore the effectiveness and application of the Savary-Gilliard dilatation of strictures, as well as the factors influencing the outcome. Methods We recruited patients of dysphagia of various grades having esophageal strictures of various etiologies. The dilatation sessions were done as an outpatient procedure in the majority of patients. In all patients, preprocedural workups, such as routine investigations and esophagogastroduodenoscopy, were done. Contrast-enhanced computed tomography scans of the abdomen and barium swallow examination were done in selected patients. Results of dilatation using wire-guided dilators were reported as the number of dilatations per stricture according to their location and the mean number of sessions required to achieve the target diameter (15 mm). Evaluating clinical efficacy and adverse events were the main goals. Results A total of 250 dilatations were carried out in 112 patients, of whom 67 were females and 45 were males. The mean age of the study population was 50.38 ± 15.4 years. Post-radiation stricture was the commonest. Strictures of upper esophageal origin required the highest number of sessions (2.21 ± 0.78) for adequate dilatation compared to the middle (2.14 ± 0.83) and lower locations (1.7 ± 0.78) with a p-value of 0.004. Post-corrosive upper esophageal stricture required a greater number of sessions for adequate dilatation as compared to post-radiation strictures (3.0 ± 0 vs. 2.6 ± 0.63) with a p-value of 0.005. Conclusion Esophageal dilation for strictures produces a good outcome with minimal adverse effects or major complications. Post-radiation, post-surgical, and post-corrosive strictures are more likely to require repeated sessions for symptomatic relief.
- 1 March 2022
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 12 (2) , 312-318
Hepatogenous Diabetes - A Report from Central India
- 1 March 2022
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 12 (2) , 312-318
Hepatogenous Diabetes - A Report from Central India
- Open Access
- 1 January 2020
- Published by Elmer Press, Inc. in Gastroenterology Research
- Vol. 13 (3) , 107-113
Evaluation of Roles of MicroRNA-21 and MicroRNA-18a in Esophageal Squamous Cell Carcinoma and Comparison of Their Changes in Expression Post-Chemoradiotherapy
Evaluation of Roles of MicroRNA-21 and MicroRNA-18a in Esophageal Squamous Cell Carcinoma and Comparison of Their Changes in Expression Post-Chemoradiotherapy
- 1 January 2020
- Published by Elmer Press, Inc. in Gastroenterology Research
- Vol. 13 (3) , 107-113
Open AccessEvaluation of Roles of MicroRNA-21 and MicroRNA-18a in Esophageal Squamous Cell Carcinoma and Comparison of Their Changes in Expression Post-Chemoradiotherapy
Evaluation of Roles of MicroRNA-21 and MicroRNA-18a in Esophageal Squamous Cell Carcinoma and Comparison of Their Changes in Expression Post-Chemoradiotherapy
- 1 July 2017
- Published by Wolters Kluwer Health in Tropical Gastroenterology
- Vol. 38 (3) , 150-157
Study of role of common NOD2 gene polymorphisms in Indian patients with decompensated liver cirrhosis
Background: Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) gene polymorphisms promote intestinal bacterial translocation (BT). Three common NOD2 gene polymorphisms (R702W, G908R and 1007fs) were recently identified as important genetic risk factors for the occurrence of spontaneous bacterial peritonitis (SBP) and also for poor prognosis in western patients of liver cirrhosis. Our aim was to see the association of these three common NOD2 gene polymorphisms with SBP and other major complications of liver cirrhosis, along with disease prognosis, in Indian population cohort. Methods: Ninety seven consecutive patients of decompensated liver cirrhosis and 45 healthy controls were recruited. Baseline clinical and laboratory parameters were recorded. Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores were calculated as disease severity scores. All patients and healthy controls underwent genetic testing for the three common NOD2 gene polymorphisms. Association of these NOD2 gene polymorphisms with major complications of cirrhosis as well as with disease severity, and mortality over 6-months was studied. Results: Out of the three common NOD2 gene polymorphisms studied, only 1007fs polymorphism was identified in six (6.18%) cirrhotic patients. None of the healthy controls showed any of the three polymorphisms. There was no statistically significant association between the presence of 1007fs polymorphism and major complications of cirrhosis or with disease severity and mortality over 6-months. Conclusions: Common NOD2 gene polymorphisms are not significantly associated with SBP and other major complications of liver cirrhosis or with poor prognosis.
- 1 July 2017
- Published by Wolters Kluwer Health in Tropical Gastroenterology
- Vol. 38 (3) , 150-157
Study of role of common NOD2 gene polymorphisms in Indian patients with decompensated liver cirrhosis
Background: Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) gene polymorphisms promote intestinal bacterial translocation (BT). Three common NOD2 gene polymorphisms (R702W, G908R and 1007fs) were recently identified as important genetic risk factors for the occurrence of spontaneous bacterial peritonitis (SBP) and also for poor prognosis in western patients of liver cirrhosis. Our aim was to see the association of these three common NOD2 gene polymorphisms with SBP and other major complications of liver cirrhosis, along with disease prognosis, in Indian population cohort. Methods: Ninety seven consecutive patients of decompensated liver cirrhosis and 45 healthy controls were recruited. Baseline clinical and laboratory parameters were recorded. Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores were calculated as disease severity scores. All patients and healthy controls underwent genetic testing for the three common NOD2 gene polymorphisms. Association of these NOD2 gene polymorphisms with major complications of cirrhosis as well as with disease severity, and mortality over 6-months was studied. Results: Out of the three common NOD2 gene polymorphisms studied, only 1007fs polymorphism was identified in six (6.18%) cirrhotic patients. None of the healthy controls showed any of the three polymorphisms. There was no statistically significant association between the presence of 1007fs polymorphism and major complications of cirrhosis or with disease severity and mortality over 6-months. Conclusions: Common NOD2 gene polymorphisms are not significantly associated with SBP and other major complications of liver cirrhosis or with poor prognosis.
- Open Access
- 10 March 2017
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. XX (XX) , 1-9
Immune Dysfunction in Cirrhosis
Cirrhosis due to any etiology disrupts the homeostatic role of liver in the body. Cirrhosis-associated immune dysfunction leads to alterations in both innate and acquired immunity, due to defects in the local immunity of liver as well as in systemic immunity. Cirrhosis-associated immune dysfunction is a dynamic phenomenon, comprised of both increased systemic inflammation and immunodeficiency, and is responsible for 30% mortality. It also plays an important role in acute as well as chronic decompensation. Immune paralysis can accompany it, which is characterized by increase in anti-inflammatory cytokines and suppression of proinflammatory cytokines. There is also presence of increased gut permeability, reduced gut motility and altered gut flora, all of which leads to increased bacterial translocation. This increased bacterial translocation and consequent endotoxemia leads to increased blood stream bacterial infections that cause systemic inflammatory response syndrome, sepsis, multiorgan failure and death. The gut microbiota of cirrhotic patients has more pathogenic microbes than that of non-cirrhotic individuals, and this disturbs the homeostasis and favors gut translocation. Prompt diagnosis and treatment of such infections are necessary for better survival. We have reviewed the various mechanisms of immune dysfunction and its consequences in cirrhosis. Recognizing the exact pathophysiology of immune dysfunction will help treating clinicians in avoiding its complications in their patients and can lead to newer therapeutic interventions and reducing the morbidity and mortality rates.
- 10 March 2017
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. XX (XX) , 1-9
Open AccessImmune Dysfunction in Cirrhosis
Cirrhosis due to any etiology disrupts the homeostatic role of liver in the body. Cirrhosis-associated immune dysfunction leads to alterations in both innate and acquired immunity, due to defects in the local immunity of liver as well as in systemic immunity. Cirrhosis-associated immune dysfunction is a dynamic phenomenon, comprised of both increased systemic inflammation and immunodeficiency, and is responsible for 30% mortality. It also plays an important role in acute as well as chronic decompensation. Immune paralysis can accompany it, which is characterized by increase in anti-inflammatory cytokines and suppression of proinflammatory cytokines. There is also presence of increased gut permeability, reduced gut motility and altered gut flora, all of which leads to increased bacterial translocation. This increased bacterial translocation and consequent endotoxemia leads to increased blood stream bacterial infections that cause systemic inflammatory response syndrome, sepsis, multiorgan failure and death. The gut microbiota of cirrhotic patients has more pathogenic microbes than that of non-cirrhotic individuals, and this disturbs the homeostasis and favors gut translocation. Prompt diagnosis and treatment of such infections are necessary for better survival. We have reviewed the various mechanisms of immune dysfunction and its consequences in cirrhosis. Recognizing the exact pathophysiology of immune dysfunction will help treating clinicians in avoiding its complications in their patients and can lead to newer therapeutic interventions and reducing the morbidity and mortality rates.
- 1 January 2016
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 35 (1) , 33-39
Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis
Background Decompensated liver cirrhosis is an important cause of mortality worldwide. Various modifiable and non-modifiable factors are involved in the pathogenesis of cirrhosis and its complications. This study was aimed to evaluate the association of iron overload and disease severity in patients of liver cirrhosis and its association with HFE gene mutation. Methods Forty-nine patients with decompensated liver cirrhosis were recruited. Clinical and laboratory parameters were compared in patients with and without iron overload. C282Y and H63D gene mutation analysis was performed in all patients with iron overload. Results Iron overload was found in 20 (40.82 %) patients. A significant positive correlation of transferrin saturation with Child-Turcotte-Pugh (CTP) score (r = 0.705, p < 0.001) and model for end-stage liver disease (MELD) score (r = 0.668, p < 0.001) was found. Transferrin saturation was also independently associated with high CTP and MELD score on multivariate analysis. Mortality over 3 months was significantly more common in iron-overloaded patients (p = 0.028). C282Y homozygosity or C282Y/H63D compound heterozygosity was not found in any of the patients with iron overload. Conclusion Iron overload was significantly associated with disease severity and reduced survival in patients of decompensated liver cirrhosis.
- 1 January 2016
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 35 (1) , 33-39
Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis
Background Decompensated liver cirrhosis is an important cause of mortality worldwide. Various modifiable and non-modifiable factors are involved in the pathogenesis of cirrhosis and its complications. This study was aimed to evaluate the association of iron overload and disease severity in patients of liver cirrhosis and its association with HFE gene mutation. Methods Forty-nine patients with decompensated liver cirrhosis were recruited. Clinical and laboratory parameters were compared in patients with and without iron overload. C282Y and H63D gene mutation analysis was performed in all patients with iron overload. Results Iron overload was found in 20 (40.82 %) patients. A significant positive correlation of transferrin saturation with Child-Turcotte-Pugh (CTP) score (r = 0.705, p < 0.001) and model for end-stage liver disease (MELD) score (r = 0.668, p < 0.001) was found. Transferrin saturation was also independently associated with high CTP and MELD score on multivariate analysis. Mortality over 3 months was significantly more common in iron-overloaded patients (p = 0.028). C282Y homozygosity or C282Y/H63D compound heterozygosity was not found in any of the patients with iron overload. Conclusion Iron overload was significantly associated with disease severity and reduced survival in patients of decompensated liver cirrhosis.
- Open Access
- 8 July 2015
- Published by SAGE Publications in Tropical Doctor
- Vol. 46 (1) , 12-15
Amoebic liver abscess: a report from central India
Amoebic liver abscess is a serious but curable hepatic illness predominantly seen in tropical countries. We describe our experience of clinical presentation, laboratory parameters, radiological findings and treatment strategies. This is a retrospective analysis of 114 patients who were admitted from January 2012 to September 2014 at our centre. The mean age of presentation was 41.7 ± 13.9 years, the majority of patients were male (86.8%) with chronic alcoholism (63.2%). Most of the patients had a solitary right lobe liver abscess. Abdominal pain, fever, tachycardia and hepatomegaly were the most common clinical findings while hypoalbuminaemia, anaemia, leucocytosis and electrolyte imbalance were the most common laboratory abnormalities. A significant number of patients could be managed with antibiotics only (45.6%), percutaneous radiological drainage techniques being an important adjunct in selected cases (percutaneous needle aspiration, 20.2%; percutaneous pigtail catheter drainage, 30.7%). Surgical intervention was required in only a few cases (3.5%). Mortality was 3.5%.
- 8 July 2015
- Published by SAGE Publications in Tropical Doctor
- Vol. 46 (1) , 12-15
Open AccessAmoebic liver abscess: a report from central India
Amoebic liver abscess is a serious but curable hepatic illness predominantly seen in tropical countries. We describe our experience of clinical presentation, laboratory parameters, radiological findings and treatment strategies. This is a retrospective analysis of 114 patients who were admitted from January 2012 to September 2014 at our centre. The mean age of presentation was 41.7 ± 13.9 years, the majority of patients were male (86.8%) with chronic alcoholism (63.2%). Most of the patients had a solitary right lobe liver abscess. Abdominal pain, fever, tachycardia and hepatomegaly were the most common clinical findings while hypoalbuminaemia, anaemia, leucocytosis and electrolyte imbalance were the most common laboratory abnormalities. A significant number of patients could be managed with antibiotics only (45.6%), percutaneous radiological drainage techniques being an important adjunct in selected cases (percutaneous needle aspiration, 20.2%; percutaneous pigtail catheter drainage, 30.7%). Surgical intervention was required in only a few cases (3.5%). Mortality was 3.5%.
- 1 May 2015
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 34 (3) , 209-215
Serum interleukin 8 and 12 levels predict severity and mortality in patients with alcoholic hepatitis
Alcoholic hepatitis (AH) is a common life-threatening illness particularly when it is severe. Alcoholic liver disease is associated with cytokine imbalance. There is paucity of information about the relationship of interleukin (IL) levels with severity and mortality of patients with AH. Our aim was to correlate serum IL-8 and IL-12 values with disease severity (mild vs. severe) and mortality. Fifty patients and 25 healthy subjects were included in the study. Serum IL-8 and -12 levels were analyzed and correlated with disease severity and mortality. Predictive value for 6 months mortality of IL-8, IL-12, Maddreys discriminant function (mDF), age, bilirubin, international normalized ratio, and creatinine score (ABIC) and Glasgow alcoholic hepatitis score (GAHS) was compared by the area under the receiver operating curve (AUROC). Mean (±SD) serum IL-8 levels were significantly higher in patients with severe AH as compared to mild AH [539.04 ± 89.77 vs. 253.66 ± 56.66 pg/mL (p < 0.001)] and controls [539.04 ± 89.77 vs. 99.96 ± 20.94 pg/mL (p < 0.001)]. Similarly, mean (+SD) serum IL-12 levels in severe AH were also significantly higher as compared to mild AH [344.47 ± 93.04 vs. 101.92 ± 16.70 pg/mL (p < 0.001)] and controls [344.47 ± 93.04 vs. 47.84 ± 11.22 pg/mL (p < 0.001)]. AUROCs of IL-8, IL-12, mDF, ABIC, and GAHS were 0.995, 0.998, 0.975, 0.873, and 0.883 for predicting 6 months mortality. Serum IL-8 and -12 levels were markedly elevated in AH with increasing levels as the severity increases. Serum levels of IL-8 and -12 were better predictors of short-term mortality as compared to conventional prognostic scores.
- 1 May 2015
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 34 (3) , 209-215
Serum interleukin 8 and 12 levels predict severity and mortality in patients with alcoholic hepatitis
Alcoholic hepatitis (AH) is a common life-threatening illness particularly when it is severe. Alcoholic liver disease is associated with cytokine imbalance. There is paucity of information about the relationship of interleukin (IL) levels with severity and mortality of patients with AH. Our aim was to correlate serum IL-8 and IL-12 values with disease severity (mild vs. severe) and mortality. Fifty patients and 25 healthy subjects were included in the study. Serum IL-8 and -12 levels were analyzed and correlated with disease severity and mortality. Predictive value for 6 months mortality of IL-8, IL-12, Maddreys discriminant function (mDF), age, bilirubin, international normalized ratio, and creatinine score (ABIC) and Glasgow alcoholic hepatitis score (GAHS) was compared by the area under the receiver operating curve (AUROC). Mean (±SD) serum IL-8 levels were significantly higher in patients with severe AH as compared to mild AH [539.04 ± 89.77 vs. 253.66 ± 56.66 pg/mL (p < 0.001)] and controls [539.04 ± 89.77 vs. 99.96 ± 20.94 pg/mL (p < 0.001)]. Similarly, mean (+SD) serum IL-12 levels in severe AH were also significantly higher as compared to mild AH [344.47 ± 93.04 vs. 101.92 ± 16.70 pg/mL (p < 0.001)] and controls [344.47 ± 93.04 vs. 47.84 ± 11.22 pg/mL (p < 0.001)]. AUROCs of IL-8, IL-12, mDF, ABIC, and GAHS were 0.995, 0.998, 0.975, 0.873, and 0.883 for predicting 6 months mortality. Serum IL-8 and -12 levels were markedly elevated in AH with increasing levels as the severity increases. Serum levels of IL-8 and -12 were better predictors of short-term mortality as compared to conventional prognostic scores.
- Open Access
- 1 April 2013
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 04 (02) , 042-043
Gastrojejunostomy stomal polyp presenting as stomal obstruction and its endoscopic management
We report the case of a 42-year-old male who presented with postprandial, non bilious, non projectile vomiting for 4 months. Patient underwent gastrojejunostomy 10 years back for post corrosive gastric outlet obstruction. General physical and systemic examinations were within normal limits. Routine laboratory investigations including complete blood count, liver and renal function tests were also within normal limits. Upper gastrointestinal endoscopy revealed solitary pedunculated polyp at the gastrojejunostomy site almost completely obstructing the lumen at the gastrrojejunostomy site. Endoscopic snare polypectomy of the gastrojejunostomy site polyp was done. Histopathological examination of the polyp was suggestive of hyperplastic polyp. After snare polypectomy patient became asymptomatic and is doing well at 6 months of follow up. (J Dig Endosc 2013;4(2):42-43)
- 1 April 2013
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 04 (02) , 042-043
Open AccessGastrojejunostomy stomal polyp presenting as stomal obstruction and its endoscopic management
We report the case of a 42-year-old male who presented with postprandial, non bilious, non projectile vomiting for 4 months. Patient underwent gastrojejunostomy 10 years back for post corrosive gastric outlet obstruction. General physical and systemic examinations were within normal limits. Routine laboratory investigations including complete blood count, liver and renal function tests were also within normal limits. Upper gastrointestinal endoscopy revealed solitary pedunculated polyp at the gastrojejunostomy site almost completely obstructing the lumen at the gastrrojejunostomy site. Endoscopic snare polypectomy of the gastrojejunostomy site polyp was done. Histopathological examination of the polyp was suggestive of hyperplastic polyp. After snare polypectomy patient became asymptomatic and is doing well at 6 months of follow up. (J Dig Endosc 2013;4(2):42-43)